Research Focus: What Happens to the Brain After 50?

Written by N. Streawbridge| 29 April 2026

Share this article

New research suggests that brain ageing may involve changes in the cells that protect, nourish and organise the brain—not simply the gradual loss of neurons.

When we think about the ageing brain, we often imagine neurons slowly wearing out or dying. But important new research suggests that something more complex may be happening.


The brain is not simply a collection of nerve cells. It is a living cellular community in which neurons depend upon immune cells, astrocytes, blood vessels, supporting tissues and carefully organised gene activity. Together, these systems continually:


  • nourish neurons;
  • remove damaged material;
  • regulate inflammation;
  • maintain the blood–brain barrier;
  • support communication between cells;
  • preserve memory and learning;
  • and create the conditions required for repair.


Research published in Science in 2026 suggests that this supporting ecology may undergo substantial reorganisation during midlife and later adulthood.


A closer look at the ageing hippocampus.


The researchers examined postmortem samples of the hippocampus from 40 neurologically healthy adults between the ages of 20 and 95. The hippocampus is a region of the brain that plays a particularly important role in memory, learning and spatial orientation.


Using advanced single-cell and genomic techniques, the researchers studied:


  • which types of cells were present;
  • which genes those cells were using;
  • the epigenetic changes influencing gene activity;
  • and how DNA was physically arranged inside the cell nucleus.


This final point is especially important. DNA is not stored inside the nucleus as a loose, random thread. It is folded into a highly organised three-dimensional structure. This organisation helps determine which genes can be accessed, which genes remain silent and how a cell preserves its specialised identity.


The study found both gradual and nonlinear changes across adulthood, with a particularly important period of transition appearing between approximately 50 and 75 years of age.


The brain’s resident immune cells appeared to change


Microglia are the specialised resident immune cells of the brain. They constantly survey the surrounding tissue and help to:


  • remove damaged cells and cellular debris;
  • respond to infection and injury;
  • regulate inflammation;
  • remodel synapses;
  • and coordinate repair.


Microglia develop from cells established early in embryonic life. They have traditionally been understood as a long-lived, self-renewing population that remains within the brain throughout adulthood.


The new study found that embryonic or yolk-sac-derived microglia progressively declined between approximately 50 and 75 years of age. They were increasingly replaced by cells whose molecular and epigenetic characteristics resembled immune cells derived from circulating blood monocytes.


These replacement-like cells also carried stronger inflammatory signatures. This does not yet prove that researchers directly observed blood monocytes travelling into the brains of living people. The likely origin of the cells was inferred from their molecular and epigenetic identity.

Nevertheless, the finding raises an important possibility: some ageing brains may gradually lose part of their original, highly specialised immune-cell population and replace it with cells that are not identically adapted to the brain environment.


Why might microglial replacement matter?


Microglia are not simply inflammatory cells. In a healthy brain, they are highly specialised maintenance cells. They must be able to distinguish between:


  • material that should be removed;
  • healthy cells that should be protected;
  • synapses that require remodelling;
  • temporary inflammatory signals;
  • and genuine threats that require a stronger immune response.


If long-established resident microglia are replaced by cells arriving from the circulation, an important question arises:


Can the incoming cells fully acquire the specialised identity and regulatory behaviour required by the brain?


A cell may begin to resemble a microglial cell and express some of the same markers without necessarily acquiring the same developmental history, chromatin organisation, metabolic programming or relationship with surrounding neurons and astrocytes. The issue may therefore be more complex than a simple change in cell numbers. It may involve a change in the quality, identity and integration of the brain’s immune population.


Astrocytes also declined


The study also found a substantial reduction in astrocytes, including populations involved in regulating synaptic transmission. Changes were also observed in endothelial and other supporting cells.


Astrocytes are sometimes described as support cells, but that description seriously understates their importance. They help to:


  • supply neurons with metabolic fuel;
  • regulate neurotransmitters;
  • maintain water and ion balance;
  • support the environment around synapses;
  • regulate local immune activity;
  • maintain the blood–brain barrier;
  • and coordinate communication between neurons and the circulation.


A decline in astrocytes could therefore weaken several maintenance systems simultaneously.

These include:


  • energy provision;
  • synaptic regulation;
  • vascular support;
  • neurotransmitter recycling;
  • inflammatory control;
  • and tissue repair.


The ageing neuron may therefore be affected not only by changes within itself, but also by the gradual loss of the cells that feed, protect and organise its environment.


The three-dimensional organisation of the genome deteriorated



One of the most intriguing findings was widespread disruption of three-dimensional genome architecture across multiple brain-cell types. The genome contains the cell’s genetic information, but its physical organisation helps determine how that information is used.


Genes that need to work together may be brought into physical proximity. Other regions may be folded away and kept inactive. This spatial arrangement helps:


  • a neuron remain a neuron;
  • an astrocyte remain an astrocyte;
  • a microglial cell maintain its specialised immune identity;
  • and each cell respond appropriately to its environment.


As this three-dimensional architecture became less organised with age, the researchers also observed changes in gene regulation and cellular identity. This suggests that brain ageing may involve more than genetic mutations or damaged DNA. Cells may gradually lose some of the regulatory organisation required to:


  • access the correct genes;
  • silence inappropriate genes;
  • respond to stress;
  • preserve their specialised identity;
  • communicate with neighbouring cells;
  • and complete repair successfully.


The ageing brain may be losing organisation


These findings support a broader way of understanding brain ageing. The problem may not simply be that individual neurons deteriorate. The cellular environment that maintains those neurons may progressively lose organisation.


A possible sequence is:


loss or changing identity of specialised microglia

→ increased or poorly regulated inflammatory signalling

→ declining astrocytic and vascular support

→ weaker clearance, metabolism and repair

→ disruption of chromatin organisation and cellular identity

→ poorer synaptic maintenance and plasticity

→ declining network coordination and cognitive reserve.


This remains a systems-level interpretation rather than a proven sequence of causation.

The study cannot yet tell us which change occurs first, whether one change directly causes another, or whether several maintenance systems deteriorate together. But it encourages us to think of the brain as an ecosystem.


Healthy cognition depends not only upon the survival of neurons, but upon preservation of the coordinated environment that nourishes, protects, instructs and repairs them.


Why do some people remain mentally sharp into very advanced age?


Not everyone experiences the same degree of cognitive decline. Some people remain intellectually active, creative and highly capable well into their eighties or nineties. Researchers sometimes describe older adults whose memory remains comparable to that of people several decades younger as SuperAgers.


A separate 2026 study examined adult human hippocampal neurogenesis and identified neural stem cells, neuroblasts and immature neurons in the ageing brain. The researchers found that SuperAgers appeared to have a distinctive pattern of neurogenesis, cellular regulation and cognitive resilience.


Changes involving astrocytes, neurons and chromatin accessibility were also associated with differences in cognitive function.  This does not mean that simply producing more neurons is the complete answer. New cells must:


  • receive the correct signals;
  • mature successfully;
  • acquire the correct identity;
  • migrate to the appropriate location;
  • connect with existing cells;
  • and integrate into functioning neural networks.


The presence of stem or progenitor cells does not guarantee successful regeneration if the surrounding tissue environment has become metabolically impaired, inflammatory or disorganised.


Regeneration requires organisation


The two studies together suggest an important principle:


Regeneration requires organisation, and organisation requires signalling.

A healthy brain must be able to:


  • generate the correct signals;
  • transmit them through cells and tissues;
  • maintain receptors capable of receiving them;
  • interpret those signals accurately;
  • coordinate their timing;
  • and provide an environment in which new or repaired cells can integrate successfully.


It is therefore possible that exceptional cognitive longevity reflects preservation of the brain’s governing ecology: the coordinated cellular environment that maintains identity, restrains inappropriate inflammation and permits repair and regeneration.


In this view, the exceptionally ageing brain is not merely composed of unusually resistant neurons.

It has preserved more of the wider system that protects, nourishes, organises and renews those neurons.


Does this mean everyone’s brain changes suddenly at 50?


No. The study describes patterns identified across a relatively small collection of postmortem hippocampal samples. It does not mean that every person undergoes an identical cellular change on their fiftieth birthday.


The research was cross-sectional. It compared different people of different ages rather than following the same individuals continuously throughout life. It also examined the hippocampus rather than every region of the brain.


Although the donors were described as neurologically healthy, the study did not establish that the observed immune-cell transition directly causes:


  • memory loss;
  • Alzheimer’s disease;
  • dementia;
  • or another neurological condition.


The findings should therefore be viewed as an important biological clue—not as a diagnostic test or an inevitable prediction of decline.


What do these findings mean for an individual?


For the person reading this, the most important message is that these findings are not a prediction of inevitable mental decline. They do not mean that the brain suddenly deteriorates at 50, that everyone undergoes the same immune-cell transition, or that a person’s future cognitive health can be determined from age alone.


The study identified patterns across groups of people. It did not establish a biological timetable that applies equally to everyone. There is also currently no routine clinical test that can tell us whether:


  • a person’s resident microglia are being replaced;
  • their three-dimensional genome organisation is deteriorating;
  • their astrocyte population is declining;
  • or these particular cellular changes will eventually affect their memory.


What the research does suggest is that healthy brain ageing may depend upon much more than keeping neurons alive. It may depend upon preserving the wider environment that allows neurons to function. That includes:


  • healthy blood vessels;
  • an intact blood–brain barrier;
  • metabolically competent astrocytes;
  • appropriately regulated immune cells;
  • effective clearance of damaged material;
  • adequate sleep and circadian restoration;
  • continued synaptic activity;
  • cognitive engagement;
  • and control of vascular, metabolic and inflammatory burdens.


This changes the emphasis from waiting for memory loss to appear towards supporting the systems that maintain the brain throughout life. Current evidence-based dementia-risk guidance supports:


  • regular physical activity;
  • avoiding tobacco;
  • limiting harmful alcohol exposure;
  • maintaining social connection;
  • continuing cognitive and educational engagement;
  • protecting hearing;
  • and identifying and managing conditions such as high blood pressure, diabetes and high cholesterol.


These measures cannot guarantee that cognitive decline will be prevented.

They have also not been proven to stop the specific microglial transition or restore the three-dimensional genome changes described in this study. They are, however, among the best-supported ways of reducing avoidable pressure on the ageing brain.


It is also important not to dismiss noticeable cognitive changes as “just ageing.”

Occasional difficulty recalling a name is not necessarily the same as a persistent change in:


  • memory;
  • language;
  • judgement;
  • orientation;
  • personality;
  • or the ability to manage ordinary daily life.


Dementia becomes more common with advancing age, but it is not an inevitable consequence of getting older. Persistent or progressive cognitive changes deserve appropriate medical assessment. Reversible or treatable contributors can include medication effects, sleep disorders, depression, thyroid dysfunction, vitamin deficiencies, hearing impairment and vascular or metabolic disease. The most useful personal question may therefore not be:


“How old is my brain?”


It may be:


“How well are the systems that nourish, protect, organise and repair my brain functioning—and what pressures upon them can be identified and reduced?”

This is a more hopeful and more precise way to approach brain ageing. It recognises that vulnerability may develop long before obvious symptoms, but also that people differ greatly in their biology, health history, exposures and remaining cognitive reserve.


The findings therefore offer neither a reason for complacency nor a reason for fear.

They offer a framework for earlier attention: protect the brain’s vascular, metabolic, immune and regenerative environment before its reserve has been substantially lost.


What does the research mean for treatment?


At present, no medicine, supplement or medicinal herb has been proven to prevent the proposed microglial transition or restore the three-dimensional organisation of the ageing human brain.

The research does, however, change the questions that scientists and clinicians may need to ask.

Rather than focusing only on protecting neurons, future approaches may need to investigate how to:


  • preserve resident microglial identity;
  • reduce excessive microglial workload;
  • support mitochondrial and lysosomal function;
  • maintain healthy astrocytes;
  • protect the neurovascular unit;
  • preserve the blood–brain barrier;
  • regulate communication between the circulation and the brain;
  • preserve chromatin organisation;
  • support the successful maturation and integration of new neurons;
  • and maintain cognitive and physiological reserve.

The objective would not be to suppress the immune system indiscriminately. Microglia are essential for:


  • surveillance;
  • debris removal;
  • synaptic organisation;
  • defence;
  • and repair.


The more precise goal would be to preserve the conditions in which these cells can remain appropriately specialised, metabolically competent and responsive. Future treatments may therefore need to act at several interconnected levels rather than targeting one inflammatory molecule or one cell type.


Supporting the brain’s governing ecology


The emerging aim is not simply to stimulate regeneration. It is to preserve or restore the environment in which regeneration can occur successfully. This may require attention to:


Cellular identity

Can neurons, astrocytes and microglia continue to access the genes required for their specialised roles?


Energy and metabolic support

Can cells produce enough energy to maintain signalling, repair, clearance and synaptic function?


Immune regulation

Can microglia respond to genuine danger without remaining chronically activated?


Clearance and recycling

Can cells remove damaged proteins, lipids, mitochondria and cellular debris efficiently?


Vascular and barrier integrity

Can the brain receive oxygen, nutrients and appropriate immune information while limiting inappropriate entry of inflammatory cells and substances?


Repair and regeneration

Can stem and progenitor cells mature, acquire the correct identity and integrate into functioning networks?


Communication and timing

Can cells generate, receive and interpret the correct signals at the correct time?


Functional reserve

Can the brain still adapt to illness, psychological stress, sleep disruption, metabolic demand and other challenges?


This systems-level approach may ultimately prove more useful than searching for a single “anti-ageing” treatment.


A new way of thinking about healthy brain ageing


This research invites us to move beyond the idea that the brain simply wears out with time.

Ageing may involve a progressive weakening of the systems that maintain:


  • cellular identity;
  • communication;
  • metabolism;
  • repair;
  • clearance;
  • vascular integrity;
  • and organisation.


The hopeful implication is that decline is unlikely to be governed by neurons alone. It may be influenced by the wider physiological environment in which neurons live.


Understanding that environment may eventually help researchers identify why some brains remain remarkably resilient—and how the conditions supporting healthy cognition might be preserved for longer.


Exceptional cognitive longevity may represent preservation of the brain’s governing ecology—the coordinated cellular environment that maintains identity, restrains inappropriate inflammation and permits regeneration—rather than resistance by neurons alone.

And more broadly:


Ageing is not only the accumulation of damage. It may also be the gradual loss of the organisational and signalling conditions that allow living tissues to maintain, repair and regenerate themselves.



References

Zemke NR, Lee S, Mamde S, et al. Epigenetic and 3D genome reprogramming during the aging of the human hippocampus. Science. 2026;393(6809). doi:10.1126/science.adt8307.

Disouky A, Sanborn MA, Sabitha KR, et al. Human hippocampal neurogenesis in adulthood, ageing and Alzheimer’s disease. Nature. 2026;652:1264–1273. doi:10.1038/s41586-026-10169-4.

World Health Organization. Risk reduction of cognitive decline and dementia: WHO guidelines.

World Health Organization. Dementia fact sheet.



Educational disclaimer

This article is provided for educational purposes only. It does not constitute medical advice, diagnosis or treatment.

The research discussed is emerging and does not establish that the cellular changes described occur in every person or that they can currently be measured, prevented or reversed in routine clinical practice.

Anyone experiencing persistent or progressive changes in memory, language, judgement, orientation, personality or daily functioning should seek assessment from an appropriately qualified healthcare professional.


Recent Posts

By Natalia Strawbridge August 31, 2026
How measured botanicals, controlled maceration and written formulas began to give bitters a recognisable pharmaceutical form
By Natalia Strawbridge August 30, 2026
The Two-Nutrient Combination That Improved Strength, Memory and Glutathione
By Natalia Strawbridge August 29, 2026
Understanding what keeps the nervous system on alert — and how to help it recover.
By Natalia Strawbridge August 28, 2026
One vine, five medicinal materials—from ancient remedy to modern pharmacy
By Natalia Strawbridge August 24, 2026
Where the story of bitters begins—not with bitterness, but with spices, herbs and fermentation.
By Natalia Strawbridge August 24, 2026
What inflammation resolution is teaching us about vascular damage, arterial stiffness and a possible new therapeutic target
By Natalia Strawbridge August 24, 2026
A patient recently came to Wildberry Clinic because she was repeatedly waking during the night with painful cramps in her legs. Like many people, she assumed the answer was magnesium. She bought a magnesium supplement and started taking it herself. But the cramps continued. That raised a more useful clinical question: Why was she getting nocturnal leg cramps in the first place? Because a night-time leg cramp is a symptom — not a diagnosis. What is a nocturnal leg cramp? A true muscle cramp is a sudden, involuntary and often intensely painful contraction of a muscle. At night it most commonly affects the calf or foot, although other muscles can be involved. The muscle may become visibly or palpably hard, and the episode can last from seconds to several minutes. Occasional nocturnal cramps are extremely common and are often benign. But recurrent, severe or newly developing cramps deserve a broader look. Different possibilities: what could be causing the cramps? 1. Idiopathic nocturnal leg cramps Sometimes there is no identifiable underlying disease. Nocturnal leg cramps become more common with age, and alterations in neuromuscular excitability, muscle shortening, physical activity and biomechanics may all contribute. But “idiopathic” should not simply be assumed before taking a proper history. 2. Chronic venous disease Venous disease is an important part of the differential. Chronic venous insufficiency and varicose veins can be associated with aching, heaviness, swelling and nocturnal cramps . Clues that make us think more carefully about the venous circulation include: visible varicose veins; ankle or lower-leg swelling; legs that feel heavy, aching or tired; symptoms becoming worse after prolonged standing; skin changes around the ankle or lower leg. A cramp alone does not diagnose venous disease, but cramps occurring within this wider pattern deserve vascular assessment. 3. Arterial disease Peripheral arterial disease produces a different pattern. Classically, patients describe calf discomfort when walking that improves with rest. More advanced arterial insufficiency may cause pain at rest, particularly in the foot, together with coldness, colour changes, poor wound healing or reduced peripheral pulses. Not every painful leg symptom at night is therefore a muscle cramp. 4. Neurological causes Muscle contraction ultimately depends on nerve signalling. Peripheral neuropathy, nerve-root irritation or compression and some neuromuscular disorders can therefore produce cramping. We become particularly interested in a neurological cause when cramps occur alongside: numbness; tingling; burning; weakness; altered sensation; muscle wasting; fasciculations; back pain radiating into the leg. Diabetes is relevant here because peripheral neuropathy may alter sensory and motor nerve function. 5. Electrolyte disturbances This is where magnesium belongs — as one part of the differential rather than the default explanation. Abnormalities involving magnesium, potassium, calcium or sodium can affect neuromuscular function. They become more plausible in situations involving: vomiting or diarrhoea; significant sweating; dehydration; restrictive diets; malabsorption; kidney disease; certain medicines. The clinical circumstances matter more than simply assuming that every cramp represents magnesium deficiency. But what about magnesium? Magnesium is essential for normal nerve and muscle function. True magnesium deficiency can increase neuromuscular excitability and may produce cramps, tremor and other symptoms. But taking magnesium because you have cramps does not prove that you were magnesium deficient. And more is not necessarily better. Too much magnesium can also be dangerous The kidneys normally remove excess magnesium, so significant hypermagnesaemia — an abnormally high magnesium concentration in the blood — is uncommon in people with normal kidney function. The risk becomes substantially greater when renal function is impaired, particularly if someone is taking magnesium-containing supplements, laxatives or antacids. Early excessive intake may produce gastrointestinal effects such as diarrhoea. With significant hypermagnesaemia, however, magnesium begins to suppress neuromuscular and cardiovascular function. Symptoms can include: muscle weakness; reduced reflexes; drowsiness; low blood pressure; slowed breathing; abnormalities of cardiac conduction. Severe magnesium toxicity can cause profound hypotension, respiratory depression and, at very high concentrations, cardiac arrest. This is particularly important in people with reduced kidney function , because their ability to excrete magnesium is impaired. So repeatedly increasing magnesium because cramps persist is not a sensible substitute for finding out why the cramps are occurring. 6. Medication-related cramps A medication review is essential. Some medicines may contribute directly to muscle symptoms, while others can change fluid or electrolyte balance. Particular attention should be paid to recent medication changes and to medicines such as diuretics where electrolyte disturbance may occur. Patients should not stop prescribed medicines themselves, but recurrent cramps are a good reason to review the medication list with a clinician. 7. Exercise, muscle fatigue and biomechanics Both too much and too little loading can matter. A sudden increase in exercise, prolonged standing, repetitive muscle use or significant muscular fatigue may precipitate cramps. At the other extreme, prolonged sitting, reduced ankle mobility and shortening or deconditioning of the calf muscles may also contribute. Foot mechanics and footwear are therefore worth considering rather than viewing the problem exclusively through a biochemical lens. 8. Pregnancy Nocturnal leg cramps are common during pregnancy. The cause is likely multifactorial and may include changes in circulation, mechanical loading, fluid distribution and neuromuscular physiology. Again, this does not automatically mean that the mother requires magnesium supplementation. 9. Systemic disease Persistent cramps can occasionally accompany broader medical conditions, including: diabetes; kidney disease; liver disease; thyroid or other metabolic disorders; some neurological diseases. The presence of cramps does not diagnose any of these conditions. It simply means that the surrounding clinical picture matters. And sometimes it isn't a cramp at all One of the most important parts of assessment is establishing what the patient actually means by “cramp.” Night-time leg symptoms can also arise from: restless legs syndrome; peripheral neuropathy; radicular pain from the spine; venous aching or heaviness; arterial rest pain; joint or soft-tissue pain. These conditions require very different approaches. What do we ask? When somebody presents with recurrent nocturnal leg cramps, useful questions include: When did they begin? How often do they occur? Are they in one leg or both? Which muscles are affected? Is there swelling, heaviness or visible venous disease? Is there numbness, tingling or weakness? Does walking bring on calf pain? Has exercise recently changed? Has there been vomiting, diarrhoea, excessive sweating or dehydration? What medications and supplements are being taken? Is there diabetes, kidney disease or another relevant medical condition? Those answers determine whether examination or investigations are needed. What can you do when a cramp happens? For a typical calf cramp, gently stretching the affected muscle can help. Straighten the knee and bring the foot upwards towards the shin to stretch the calf. Getting out of bed and gently walking may also help, as can gentle massage. But recurrent cramps should not simply lead to progressively larger doses of supplements. The Clinical Insight Our patient's magnesium had not solved the problem because “night cramps” and “magnesium deficiency” are not interchangeable diagnoses. Magnesium is one possibility. So are venous disease, neurological problems, medication effects, electrolyte abnormalities, muscle fatigue, pregnancy, systemic disease — or simply idiopathic nocturnal cramping. The useful question is therefore not: “Which magnesium should I take?” It is: “Why is this muscle cramping?” That distinction can completely change the clinical assessment — and sometimes reveal something much more important than a nutritional deficiency. Disclaimer This article is for educational purposes only and is not intended to diagnose or treat any medical condition or replace individual medical assessment. Nocturnal leg cramps have many possible causes, and recurrent, severe, newly developing or unexplained cramps should be assessed in the context of the person’s medical history, medications, examination and, where appropriate, investigations. Supplements, including magnesium, should not be assumed to be necessary solely because cramps are present. Particular caution is required with magnesium supplementation in people with impaired kidney function, as excessive magnesium can accumulate in the blood and, in severe cases, affect neuromuscular, respiratory and cardiovascular function. References Garrison SR, Korownyk CS, Kolber MR, Allan GM, Musini VM, Sekhon RK, Dugré N. Magnesium for skeletal muscle cramps. Cochrane Database of Systematic Reviews. 2020;9:CD009402. doi:10.1002/14651858.CD009402.pub3. The review found that magnesium is unlikely to provide clinically meaningful prevention of idiopathic cramps in older adults; evidence for pregnancy-associated cramps remains uncertain. De Maeseneer MG, Kakkos SK, Aherne T, et al. European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. European Journal of Vascular and Endovascular Surgery. 2022;63(2):184–267. doi:10.1016/j.ejvs.2021.12.024. Relevant to the association of chronic venous disease with symptoms including aching, heaviness, swelling and nocturnal cramps. Lewis JL III. Hypermagnesemia. Merck Manual Professional Edition. Reviewed June 2025; updated December 2025. Hypermagnesaemia is uncommon with normal renal function but occurs particularly in renal failure following exposure to magnesium-containing preparations; severe toxicity can cause hyporeflexia, hypotension, respiratory depression, cardiac conduction abnormalities and cardiac arrest. Lewis JL III. Overview of Disorders of Magnesium Concentration. Merck Manual Professional Edition. Reviewed June 2025. Useful background on magnesium physiology, serum magnesium interpretation and renal regulation of magnesium balance. Clinical herbal medicine grounded in science and individualised care.
By Natalia Strawbridge August 23, 2026
An ancient medicinal food for blood sugar, digestion and cardiovascular health
By Natalia Strawbridge August 20, 2026
How different medical traditions understood, classified and treated head pain
By Natalia Strawbridge August 19, 2026
A new study has shown that an engineered enzyme can remove a specific form of age-associated chemical damage from proteins in human tissues.
Show More